Kymera Therapeutics Inc. (KYMR)
Market Open
3 Mar, 17:11
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
88. 02
-2.08
-2.3%
$
7.31B Market Cap
- P/E Ratio
- Div Yield
0 Volume
-2.54 Eps
$ 90.1
Previous Close Day Range
86.11 88.96
Year Range
19.45 103
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
KYMR earnings report is expected in 58 days (30 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KYMR Earnings Reports FAQ
What is the earnings per share (EPS) for KYMR?
The current EPS is -2.54.
What is the company's earnings growth rate?
Kymera Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-30, based on the KYMR's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kymera Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KYMR at this time, as Kymera Therapeutics Inc has no recent EPS data to calculate it.
